What's New
05/11/2022 – The Melanoma Research Alliance Names Dr. Marc Hurlbert as Chief Executive Officer
05/09/2022 – Dr. Gary Deng & The Wellness Principles
04/21/2022 – A Message from the Melanoma Research Alliance
03/18/2022 – MRA Statement on FDA Approval of Relatlimab + Nivolumab for Treatment of Advanced Melanoma
01/26/2022 – MRA Celebrates Approval of Tebentafusp - First Drug for Metastatic Uveal Melanoma